ATLANTA, GA – – (Globe Newswire – March 20, 2024) – – Holzer & Holzer, LLC is investigating whether Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) complied with federal securities laws. On March 20, 2024, Lifecore filed its Annual Report on Form 10-K for the fiscal year ended May 28, 2023, which contained restatements of certain previously issued financial statements that corrected “errors involving the calculation of capitalized interest, valuation of inventories, and certain other adjustments related to previously divested businesses.” Following this news, the Company’s stock price declined.

If you purchased Lifecore stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share